The Division of Rheumatology strives to understand more about Spondyloarthritis through research. Please see the list below, which summarizes the studies available to individuals interested in advancing our understanding and treatment of rheumatic disease.
|Basic Eligibility Criteria
Program for individuals
Liron Caplan, MD
study of individuals
at risk of spondyloarthritis (SpA).
This study does not
include a placebo group.
|1) Parent, child, or sibling
(by blood) of
2) Individuals with SpA
or SpA associated
conditions such as
disease, psoriasis, or
or click here to give your information to the study team.
Interdisciplinary Joint Biology Program for Rheumatic and Orthopedic Diseases
Larry Moreland, MD
|The goal of the University of Colorado Interdisciplinary Joint Biology Program is to employ cutting edge science and technology to advance research of inflammatory, degenerative and musculoskeletal joint diseases
Individuals with RA, SpA, PsA, AS, OA or any other form of inflammatory arthritis with active disease in their elbow, wrist, hand joints, knee, ankle or shoulder and are willing to undergo a synovial biopsy at that site
individuals who are having an orthopedic surgery and are willing to donate their tissues that would normally be discarded